Skip to main content
Erschienen in: Annals of Surgical Oncology 2/2019

11.12.2018 | Gynecologic Oncology

Laterally Extended Pelvic Resection for Gynaecological Malignancies: A Multicentric Experience with Out-of-the-Box Surgery

verfasst von: Giuseppe Vizzielli, MD, PhD, Raj Naik, MD, Lukas Dostalek, MD, Nicolò Bizzarri, MD, Ali Kucukmetin, MD, Giovanni Tinelli, MD, Giovanni Scambia, MD, David Cibula, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate morbidity and oncological outcome in a multicentre series of women with gynaecological malignancies infiltrating pelvic side wall (PSW) that received laterally extended pelvic resection (LEPR).

Methods

Patients operated between 2007 and 2017 at three institutions were included. LEPR was defined as an en bloc lateral resection of a pelvic tumour involving sidewall muscle, and/or bone, and/or major nerve, and/or major vascular structure. Postsurgical complications and survivals were evaluated.

Results

Sixty-three women with gynaecological tumours involving PSW were treated with LEPR. Five women underwent primary LEPR, whereas 58 (92%) patients needed LEPR because of recurrence. Twenty-four women (38%) received previous radiation therapy before the surgery. R0 resection was achieved in 54 patients (85.7%), whereas the pathologic margins were microscopically and macroscopically positive in 8 (12.7%) patients and 1 (1.6%) patient, respectively. There was one perioperative death, whereas major postoperative complications occurred in 17 patients (27.7%). Thirty (47.5%) women experienced recurrences: 24/54 (44.4%) were in the R0 group, and 6/9 (66.6%) were in the R1 group, with a median PFS of 15 months and 7 months, respectively (p = 0.024). In total, 11 of 54 (20.3%) patients died of disease in the R0 group and 5 of 9 (55.5%) in the R1 group; a median OS was not reached and was 32 months for R0 and R1 groups, respectively (p = 0.033).

Conclusions

Involvement of the PSW should not prevent obtaining R0 resection. Although the LEPR is associated with considerable morbidity (≈ 30%), a long-term survival seems to be achieved in those women with complete resection.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ang C, Bryant A, Barton DP, Pomel C, Naik R. Exenterative surgery for recurrent gynaecological malignancies. Cochrane Database Syst Rev. 2014;(2):CD010449. Ang C, Bryant A, Barton DP, Pomel C, Naik R. Exenterative surgery for recurrent gynaecological malignancies. Cochrane Database Syst Rev. 2014;(2):CD010449.
2.
Zurück zum Zitat Hoeckel M. Long-term experience with (laterally) extended endopelvic resection (LEER) in relapsed pelvic malignancies. Curr Oncol Rep. 2015;17(3):435. Hoeckel M. Long-term experience with (laterally) extended endopelvic resection (LEER) in relapsed pelvic malignancies. Curr Oncol Rep. 2015;17(3):435.
3.
Zurück zum Zitat Chiantera V, Rossi M, De Iaco P, et al. Morbidity after pelvic exenteration for gynecological malignancies: a retrospective multicentric study of 230 patients. Int J Gynecol Cancer. 2014;24(1):156–64.CrossRefPubMed Chiantera V, Rossi M, De Iaco P, et al. Morbidity after pelvic exenteration for gynecological malignancies: a retrospective multicentric study of 230 patients. Int J Gynecol Cancer. 2014;24(1):156–64.CrossRefPubMed
4.
Zurück zum Zitat Shaikh I, Aston W, Hellawell G, et al. Extended lateral pelvic sidewall excision (ELSiE): an approach to optimize complete resection rates in locally advanced or recurrent anorectal cancer involving the pelvic sidewall. Tech Coloproctol. 2014;18(12):1161–8.CrossRefPubMed Shaikh I, Aston W, Hellawell G, et al. Extended lateral pelvic sidewall excision (ELSiE): an approach to optimize complete resection rates in locally advanced or recurrent anorectal cancer involving the pelvic sidewall. Tech Coloproctol. 2014;18(12):1161–8.CrossRefPubMed
5.
Zurück zum Zitat Vizzielli G, Fanfani F, Costantini B, Gallotta V, Scambia G, Fagotti A. External hemipelvectomy as treatment for solitary coxofemoral metastasis from endometrial carcinoma: case report and review of the literature. J Obstet Gynaecol Res. 2012;38(5):892–8.CrossRefPubMed Vizzielli G, Fanfani F, Costantini B, Gallotta V, Scambia G, Fagotti A. External hemipelvectomy as treatment for solitary coxofemoral metastasis from endometrial carcinoma: case report and review of the literature. J Obstet Gynaecol Res. 2012;38(5):892–8.CrossRefPubMed
6.
Zurück zum Zitat Sardain H, Lavoue V, Redpath M, Bertheuil N, Foucher F, Levêque J. Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy. A systematic review. Eur J Surg Oncol. 2015;41(8):975–85. Sardain H, Lavoue V, Redpath M, Bertheuil N, Foucher F, Levêque J. Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy. A systematic review. Eur J Surg Oncol. 2015;41(8):975–85.
7.
Zurück zum Zitat Lakhman Y, Nougaret S, Miccò M, et al. Role of MR Imaging and FDG PET/CT in selection and follow-up of patients treated with pelvic exenteration for gynecologic malignancies. Radiographics. 2015;35(4):1295–313.CrossRefPubMedPubMedCentral Lakhman Y, Nougaret S, Miccò M, et al. Role of MR Imaging and FDG PET/CT in selection and follow-up of patients treated with pelvic exenteration for gynecologic malignancies. Radiographics. 2015;35(4):1295–313.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Caceres A, Mourton SM, Bochner BH, et al. Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgery. Int J Gynecol Cancer. 2008;18:1139–44.CrossRefPubMed Caceres A, Mourton SM, Bochner BH, et al. Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgery. Int J Gynecol Cancer. 2008;18:1139–44.CrossRefPubMed
9.
Zurück zum Zitat Dowdy SC, Mariani A, Cliby WA, Haddock MG, Petersen IA, Sim FH, Podratz KC. Radical pelvic resection and intraoperative radiation therapy for recurrent endometrial cancer: technique and analysis of outcomes. Gynecol Oncol. 2006;101:280–6.CrossRefPubMed Dowdy SC, Mariani A, Cliby WA, Haddock MG, Petersen IA, Sim FH, Podratz KC. Radical pelvic resection and intraoperative radiation therapy for recurrent endometrial cancer: technique and analysis of outcomes. Gynecol Oncol. 2006;101:280–6.CrossRefPubMed
10.
Zurück zum Zitat Andikyan V, Khoury-Collado F, Sonoda Y, et al. Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: an update on out of the box surgery. Gynecol Oncol. 2012;125(2):404–8.CrossRefPubMed Andikyan V, Khoury-Collado F, Sonoda Y, et al. Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: an update on out of the box surgery. Gynecol Oncol. 2012;125(2):404–8.CrossRefPubMed
11.
Zurück zum Zitat Goldberg GL, Sukumvanich P, Einstein MH, Smith HO, Anderson PS, Fields AL. Total pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987 to 2003). Gynecol Oncol. 2006;101:261–8.CrossRefPubMed Goldberg GL, Sukumvanich P, Einstein MH, Smith HO, Anderson PS, Fields AL. Total pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987 to 2003). Gynecol Oncol. 2006;101:261–8.CrossRefPubMed
12.
Zurück zum Zitat Tewari KS, Sill MW, Penson RT, et al. Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240). Lancet. 2017;390:1654–63.CrossRefPubMedPubMedCentral Tewari KS, Sill MW, Penson RT, et al. Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240). Lancet. 2017;390:1654–63.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Solomon MJ, Brown KG, Koh CE, Lee P, Austin KK, Masya L. Lateral pelvic compartment excision during pelvic exenteration. Br J Surg. 2015;102(13):1710–7.CrossRefPubMed Solomon MJ, Brown KG, Koh CE, Lee P, Austin KK, Masya L. Lateral pelvic compartment excision during pelvic exenteration. Br J Surg. 2015;102(13):1710–7.CrossRefPubMed
14.
Zurück zum Zitat Vizzielli G, Chiantera V, Tinelli G, et al. Out-of-the-box pelvic surgery including iliopsoas resection for recurrent gynecological malignancies: does that make sense? A single-institution case-series. Eur J Surg Oncol. 2017;43(4):710–6.CrossRefPubMed Vizzielli G, Chiantera V, Tinelli G, et al. Out-of-the-box pelvic surgery including iliopsoas resection for recurrent gynecological malignancies: does that make sense? A single-institution case-series. Eur J Surg Oncol. 2017;43(4):710–6.CrossRefPubMed
15.
Zurück zum Zitat Tinelli G, Cappuccio S, Parente E, et al. Resectability and vascular management of retroperitoneal gynecological malignancies: a large single-institution case-series. Anticancer Res. 2017;37(12):6899–906.PubMed Tinelli G, Cappuccio S, Parente E, et al. Resectability and vascular management of retroperitoneal gynecological malignancies: a large single-institution case-series. Anticancer Res. 2017;37(12):6899–906.PubMed
16.
Zurück zum Zitat Cibula D, Zikan M, Fischerova D, et al. Pelvic floor reconstruction by modified rectus abdominis myoperitoneal (MRAM) flap after pelvic exenterations. Gynecol Oncol. 2017;144(3):558–63.CrossRefPubMed Cibula D, Zikan M, Fischerova D, et al. Pelvic floor reconstruction by modified rectus abdominis myoperitoneal (MRAM) flap after pelvic exenterations. Gynecol Oncol. 2017;144(3):558–63.CrossRefPubMed
17.
Zurück zum Zitat Cibula D. Pelvic Exenteration for gynecological cancers. In: Ramirez PT, Frumovitz M, Abu-Rustum N (eds) Principles of gynecologic oncology surgery. Publisher Elsevier, Philadelphia; 2018. Cibula D. Pelvic Exenteration for gynecological cancers. In: Ramirez PT, Frumovitz M, Abu-Rustum N (eds) Principles of gynecologic oncology surgery. Publisher Elsevier, Philadelphia; 2018.
18.
Zurück zum Zitat Costantini B, Vizzielli G, Fanfani F, et al. Urologic surgery in gynecologic oncology: a large single-institution experience. Eur J Surg Oncol. 2014;40(6):756–61.CrossRefPubMed Costantini B, Vizzielli G, Fanfani F, et al. Urologic surgery in gynecologic oncology: a large single-institution experience. Eur J Surg Oncol. 2014;40(6):756–61.CrossRefPubMed
19.
Zurück zum Zitat Strong VE, Selby LV, Sovel M, et al. Development and assessment of Memorial Sloan Kettering Cancer center’s surgical secondary events grading system. Ann Surg Oncol. 2015;22(4):1061–7.CrossRefPubMed Strong VE, Selby LV, Sovel M, et al. Development and assessment of Memorial Sloan Kettering Cancer center’s surgical secondary events grading system. Ann Surg Oncol. 2015;22(4):1061–7.CrossRefPubMed
20.
Zurück zum Zitat Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–81.CrossRef Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–81.CrossRef
21.
Zurück zum Zitat Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1996;50:163–70. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1996;50:163–70.
Metadaten
Titel
Laterally Extended Pelvic Resection for Gynaecological Malignancies: A Multicentric Experience with Out-of-the-Box Surgery
verfasst von
Giuseppe Vizzielli, MD, PhD
Raj Naik, MD
Lukas Dostalek, MD
Nicolò Bizzarri, MD
Ali Kucukmetin, MD
Giovanni Tinelli, MD
Giovanni Scambia, MD
David Cibula, MD
Publikationsdatum
11.12.2018
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 2/2019
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-07088-8

Weitere Artikel der Ausgabe 2/2019

Annals of Surgical Oncology 2/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.